Australian biotech Bionomics files for IPO with plans to list on Nasdaq
Bionomics , an Australian clinical-stage biopharmaceutical company specializing in treatments for central nervous system disorders with high unmet needs, filed for an initial public offering on Tuesday. The company is plan…